Is Airsculpt Technologies Inc (AIRS) overvalued? · rev $180.3M
Airsculpt Technologies Inc (AIRS) is a medical care facilities company listed on US.
This page asks whether Airsculpt Technologies Inc (AIRS) looks expensive on cached numbers — not a short thesis.
Latest reported AIRS revenue for 2024-12-31 was $180.3M. Net income was -$8.3M. Revenue was down 7.9% from 2023-12-31 to 2024-12-31. AIRS currently screens at market cap $337.0M.
AIRS currently screens at market cap $337.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AIRS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AIRS stock page for the full model, not this heading.
Not investment advice.